Medicine and Dentistry
Age Related Macular Degeneration
100%
Visual Acuity
52%
Ranibizumab
52%
Spectral Domain Optical Coherence Tomography
39%
Macular Degeneration
31%
Macular Hole
30%
Proliferative Diabetic Retinopathy
30%
Eye Disease
30%
Choroidal Neovascularization
30%
Wet Macular Degeneration
29%
Geographic Atrophy
25%
Optical Coherence Tomography
24%
Best Corrected Visual Acuity
23%
Morphology
18%
Diabetic Macular Edema
17%
Retinal Detachment
16%
Clinical Trial
16%
Laser Coagulation
15%
Clinical Feature
15%
Steroid Treatment
15%
Macular Edema
15%
Intravitreal Administration
15%
Neuroretinitis
15%
Aflibercept
15%
Antibiotics
15%
Maculopathy
15%
Acute Posterior Multifocal Placoid Pigment Epitheliopathy
15%
Retinopathy
15%
Agents Acting on the Eye
15%
Sclera Buckling Procedure
15%
Angioid Streak
15%
Screening Test
15%
Epiretinal Membrane
15%
Cytomegalovirus Retinitis
15%
Uveitis
15%
Endophthalmitis
15%
Hydroxychloroquine
15%
Writing
15%
Nepafenac
15%
Bleeding
12%
Diseases
12%
Fluorescein Angiography
12%
Injury
11%
Randomized Clinical Trial
9%
Visual Impairment
8%
Telangiectasia
7%
Counseling
7%
Disease Process
7%
Inflammatory Infiltrate
6%
Odds Ratio
6%
Keyphrases
Clinical Comparison
30%
Intravitreal Ganciclovir
15%
Subretinal Hyperreflective Material
15%
Treat-and-extend
15%
Unilateral Acute Idiopathic Maculopathy
15%
Navigated Laser
15%
Threshold Dose
15%
Laser Photocoagulation
15%
Age-Related Eye Disease Study 2
15%
Randomized Trial
15%
Uveitic Macular Edema
15%
Macular Atrophy
15%
Hydroxychloroquine Retinopathy
15%
Neuroretinitis
15%
Flying Saucer
15%
Panuveitis
15%
Acute Posterior multifocal Placoid pigment Epitheliopathy
15%
Clinical Trial Screening
15%
Retinal Periphlebitis
15%
RECOVERY Trial
15%
Spectral Domain Optical Coherence Tomography (SD-OCT)
15%
Monthly Dosing
15%
Silicone Sponge
15%
Ophthalmic Antibiotic
15%
Topical Ophthalmic
15%
Scleral Buckling
15%
2-year Outcome
15%
Angioid Streaks
15%
Time-domain Optical Coherence Tomography
15%
Plasma Vascular Endothelial Growth Factor
15%
Ranibizumab
15%
Diabetic Macular Edema
15%
Visudyne
15%
Lucentis
15%
Spectral Domain
15%
Cytomegalovirus Retinitis
15%
Clinical Accuracy
15%
Pseudohole
15%
Macular Pseudohole
15%
Nepafenac
15%
Hydroxychloroquine Toxicity
10%
Sagittal Sinus
10%
Epimacular Membrane
8%
Photic
7%
Counseling
7%
Macular Telangiectasia
7%
Disease Process
7%
Age-related Macular Degeneration
7%
Pylephlebitis
7%
Intraretinal Cysts
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ranibizumab
85%
Diabetic Macular Edema
48%
Age Related Macular Degeneration
47%
Aflibercept
40%
Vasculotropin
38%
Wet Macular Degeneration
36%
Randomized Clinical Trial
36%
Proliferative Diabetic Retinopathy
30%
Bevacizumab
23%
Diabetic Retinopathy
21%
Macular Degeneration
20%
Endothelial Cell Growth Factor
17%
Cytomegalovirus Retinitis
15%
Retina Detachment
15%
Verteporfin
15%
Photodynamic Therapy
15%
Dexamethasone
15%
Eye Disease
15%
Subretinal Neovascularization
15%
Steroid Treatment
15%
Clinical Trial
15%
Visual Pigment
15%
Subretinal Fluid
7%
Hemiretinal Vein Occlusion
5%
Adverse Event
5%